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Introduction: During normal pulp tissue healing, inflammatory cytokines, such as tumor necrosis factor-alpha
(TNF-α) or interleukins, act in the initial 48 hours (inflammatory phase) and play important roles not only as chemo-
attractants of inflammatory cells and stem/progenitor cells but also in inducing a cascade of reactions toward tissue
regeneration or reparative dentin formation or both. Previous reports have shown that inflammatory cytokines
regulate the differentiation capacity of dental pulp stem/progenitor cells (DPCs), but none has interrogated the
impact of these cytokines on the stem cell phenotype of stem/progenitor cells. This study investigated the effects
of a short-term treatment with TNF-α on the stem cell phenotype and differentiation ability of human DPCs.
Methods: An in vivo mouse model of pulp exposure was performed for analysis of expression of the mesenchymal
stem cell marker CD146 in DPCs during the initial stage of inflammatory response. For in vitro studies, human DPCs
were isolated and incubated with TNF-α for 2 days and passaged to eliminate TNF-α completely. Analysis of stem
cell phenotype was performed by quantification of cells positive for mesenchymal stem cell markers SSEA-4
(stage-specific embryonic antigen 4) and CD146 by flow cytometry as well as by quantitative analysis of telomerase
activity and mRNA levels of OCT-4 and NANOG. Cell migration, colony-forming ability, and differentiation toward
odontogenesis and adipogenesis were also investigated.
Results: The pulp exposure model revealed a strong staining for CD146 during the initial inflammatory response, at
2 days after pulp exposure. In vitro experiments demonstrated that a short-term (2-day) treatment of TNF-α
increased by twofold the percentage of SSEA-4+ cells. Accordingly, STRO-1, CD146, and SSEA-4 protein levels as well
as OCT-4 and NANOG mRNA levels were also significantly upregulated upon TNF-α treatment. A short-term TNF-α
treatment also enhanced DPC function, including the ability to form cell colonies, to migrate, and to differentiate
into odontogenic and adipogenic lineages.
Conclusions: A short-term treatment with TNF-α enhanced the stem cell phenotype, migration, and differentiation
ability of DPCs.Introduction
The normal healing process of an injured tissue is char-
acterized by very orderly and distinct but overlapping
phases: hemostasis, inflammation, proliferation, and re-
modeling [1]. During the inflammation phase, chemo-
kines and pro-inflammatory cytokines such as interleukins
(for example, IL-1α, IL-1β, and IL-6) and tumor necrosis* Correspondence: kuboki@md.okayama-u.ac.jp
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reproduction in any medium, provided the orfactor-alpha (TNF-α) are released by activated macro-
phages at the injured site and initiate the inflammatory
cascade. The inflammatory period has its peak in the ini-
tial 48 hours and is important not only for recruiting leu-
cocytes but also for activation of surrounding connective
tissue cells, including stem/progenitor cells, that migrate
to the injured site and contribute to tissue healing, which
characterizes the proliferative and remodeling phases
[2,3]. On the other hand, feedback signaling from the cells
surrounding the injury site modulates the activation of
resident macrophages by secretion of anti-inflammatorytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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prostaglandin E2 (PGE2), and interleukin-1 receptor
antagonist (IL-1ra) to eventually suppress or terminate
the inflammatory phase.
Such a synchronized and feedback-controlled regula-
tion of inflammation and regeneration phases is crucial
for normal tissue healing, and alteration in inflammatory
signals has been reported to disrupt the normal tissue
healing. For instance, gene deletion of core inflammatory
cytokines, such as TNF-α, has been associated with im-
paired healing or pathogenic tissue response in mice [4,5].
On the other hand, extended duration of the inflammatory
phase, such as in the case of chronic inflammation, is
widely known to repress complete tissue regeneration.
Dental pulp is frequently submitted to damage or in-
jury, and, in most cases, dental pulp cells (DPCs) deposit
reparative or tertiary dentin in response to the injury [6].
In this context, previous in vitro studies have shown that
a short-term treatment with TNF-α or IL-1β (or both)
induces matrix deposition and increases the expression
of odontogenic marker genes dentinsialoprotein (DSP),
dentin matrix protein (DMP-1), and osteocalcin (OCN)
in DPCs [7,8]. On the other hand, a long-term stimula-
tion with TNF-α suppresses the differentiation ability of
DPCs [8,9].
Therefore, it is clear that pro-inflammatory cytokines
modulate the function and differentiation ability of mes-
enchymal stem/progenitor cells. However, no study has
investigated the effect of inflammatory cytokines on the
stem cell phenotype of DPCs so far. In this study, we
show, for the first time, an increase in CD146-positive
cells during the initial inflammatory phase in an in vivo
pulp exposure model. Additionally, subsequent in vitro
experiments revealed that a short-term stimulation with
TNF-α, but not with IL-1β or IL-6, enhanced the stem
cell phenotype of human DPCs as determined by telomer-
ase activity, analysis of gene expression levels of OCT-4
and NANOG, and expression of the mesenchymal stem
cell surface markers SSEA-4 (stage-specific embryonic
antigen 4) and CD146. Finally, we show that the increase
in stem cell phenotype induced by TNF-α was associated
with enhanced migration, colony formation, and multipo-
tent differentiation ability of DPCs toward odontogenic
and adipogenic lineages.
Materials and Methods
Pulp exposure model in mice
Six-week-old mice were anesthetized with intra-peritoneal
injection of a mixture of xylazine (8 mg/kg; Bayer, Tokyo,
Japan) and ketamine (80 mg/kg; Sankyo, Tokyo, Japan).
Mandibular first molars were drilled with a diamond bur
and air-turbine handpiece to expose the pulp, which was
left untreated for 2 or 4 days. Subsequently, mice were
sacrificed and mandibles were immediately immersed inembedding medium, frozen, and sectioned in 5 mm-thick
sections in accordance with a previously described method
[10]. The animals were treated in accordance with the
Guidelines for Animal Research of Okayama University
Dental School. The research protocol for animal experi-
ments was approved by the Okayama University Ethics
Committee (OKU-2013125).
Human cell isolation and culture
Human DPCs were isolated from third molars or pre-
molars of at least three adults (20 to 23 years old) at
Okayama University Hospital, and written informed
consent was obtained from all subjects in accordance
with a previously reported method [11]. Guidelines and
protocol for utilization of DPCs from human subjects
were approved by the Okayama University Ethics Com-
mittee (#418). Cells were cultured with basal medium,
consisting of alpha-minimum essential medium (α-MEM)
(Gibco BRL, New York, NY, USA), 15% fetal bovine serum
(FBS) (Invitrogen, Carlsbad, CA, USA), 100 mM L-ascorbic
acid 2-phosphate (Wako Pure Chemical Industries, Osaka,
Japan), 2 mM L-glutamine (Invitrogen), 100 units/mL
penicillin (Sigma-Aldrich, St. Louis, MO, USA), and
100 mg/mL streptomycin (Sigma-Aldrich), at 37°C under
5% CO2 in air.
For pretreatment experiments with TNF-α, DPCs were
cultured up to 60% confluence and further incubated with
10 ng/mL of recombinant human TNF-α (rhTNF-α)
(R&D Systems, Minneapolis, MN, USA) for 2 days. After
reaching sub-confluency, cells were passaged once with
accutase (Innovative Cell Technologies Inc., San Diego,
CA, USA) to remove TNF-α completely before assays.
DPCs up to the eighth passage were used in this study.
Neutralization of TNF-α receptor 1 (TNFR1) was per-
formed with human anti-TNFRI antibody (TNFR1AB;
MAB625, R&D). IL-1 and IL-6 were purchased from
R&D Systems.
Cell viability
Cell viability was assessed by a colorimetric assay based
on the bioreduction of a tetrazolium compound—3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium, inner salt; MTS—by viable
cells (CellTiter 96 AQueous One Solution Cell Prolifera-
tion Assay; Promega, Madison, WI, USA) in accordance
with the instructions of the manufacturer.
Multipotent differentiation
DPCs were induced to differentiate toward the odontogenic
lineage, based on a previous reported protocol with a few
modifications [12,13]. Briefly, DPCs were cultured up to
80% confluence and thereafter incubated in mineralization
medium—basal medium containing 10 nM dexamethasone
(Sigma-Aldrich), β-glycerophosphate (Sigma-Aldrich)—for
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of alkaline phosphatase (ALP), dentinsialophosphoprotein
(DSPP), and osteopontin (OPN) or stained for calcified
extracellular matrix by staining with 1% alizarin red S
staining solution.
Induction of adipogenic differentiation of DPCs was
performed under similar culture conditions of the odon-
togenic induction method, and cultures were incubated
in basal medium containing 1 μg/mL insulin (Sigma-
Aldrich), 0.5 mM 1-methyl-3-isobutylxanthine (Sigma-
Aldrich), and 60 μM indomethacin (Sigma-Aldrich) for
14 or 30 days. After induction, cultures were analyzed
for gene expression of adipocyte protein 2 (AP2) or
stained for oil drops with 0.5% Oil Red O staining
solution.
Reverse transcription and real-time polymerase chain
reaction
Total RNA from DPC cultures was extracted with RNeasy
(Qiagen, Hilden, Germany) and purified by removing
genomic DNA with RNase-Free DNase set (Qiagen), as
described previously [14]. Expression levels of the target
genes were normalized to that of the reference gene S29.
Primer sequences were the following: S29 (BC032813)
sense: 5′-ACACTGGCGCACATATTGAGG-3′, S29 anti-Figure 1 Pulp exposure model in mice. (A) Bright-field image of cryosec
2 and 4 days after injury. (B,C) Immunofluorescence staining for CD146. No
pulp exposure. (D) Hematoxylin and eosin staining of sections. Dotted line
cellular debris, and squares indicate the area shown at high magnification
bars = 100 μm (A,B) and 50 μm (C,D). Images are representative of three insense: 5′- TCTCGCTCTTGTCGTGTCTGTTC-3′; OCT-4
(NM_001159542) sense: 5′-CCGAGTGTGGTTCTGT
AAC-3′, OCT-4 anti-sense: 5′-GAAAGGGACCGAG
GAGTA-3′; NANOG (NM_024865) sense: 5′-TCTC
CAACATCCTGAACCT-3′, NANOG anti-sense: 5′-
GCGTCACACCATTGCTAT-3′; ALP (NM_000478)
sense: 5′-GCACCGCCACCGCCTACC-3′; ALP anti-
sense: 5′-CCACAGATTTCCCAGCGTCCTTG-3′; DSPP
(NM_014208) sense: 5′-TGGAGCCACAAACAGAAGC
AACAC-3′; DSPP anti-sense: 5′-TGGACAACAGCGA
CATCCTCATTG-3′; OPN (BC007016) sense: 5′-ATGTG
ATTGATAGTCAGGAACTT-3′; OPN anti-sense: 5′-GT
CTACAACCAGCATATCTTCA-3′; OCN (NM_199173)
sense: 5′-CAGAGTCCAGCAAAGGTG-3′; OCN anti-
sense: 5′-AGCCATTGATACAGGTAGC-3′; and AP2
(BC104842) sense: 5′-GGGTGGGCAGACTGTGGAC
TC-3′, AP2 anti-sense: 5′-AGGGAGCAGAAGAGAAG
TGTCAGG-3′.
Flow cytometry
DPCs were dissociated with accutase and filtered through
a 70-μm cell strainer, washed, resuspended in phosphate-
buffered saline (PBS) containing 1% FBS, and incubated
with antibodies (anti-human SSEA-4, CD29, CD34, CD44,
CD45, CD90, and CD146 antibody; BD Biosciences, Santions of mouse lower first molar: control and pulp exposure model at
te a strong signal intensity corresponding to CD146 at 2 days after
s indicate the drilled dentin with clear pulp exposure, arrows show
in (C). Arrowheads indicate CD146+ cells. d, dentin; p, dental pulp. Scale
dependent samples.
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washed and subjected to flow cytometry (FCM) analysis by
MACSQuant Analyzer (Miltenyi Biotec, Bergisch Gladbach,
Germany) or Accuri™ C6 (BD Biosciences).Immunofluorescence staining
Immunostaining of cryosections was performed by initial
blocking with 10% normal goat serum, followed by incu-
bation with anti-CD-146 antibody (Abcam, Cambridge,
MA, USA) or IgG (Abcam), wash, and incubation
with second antibody AlexaFluor 488 conjugated IgG
(Invitrogen).
DPCs were seeded onto 96-well plates and cultured for
24 hours in basal medium. The cells were subsequently
fixed in 4% paraformaldehyde (PFA) for 15 minutes,
permeabilized with PBS containing 0.25% Triton X-100
for 10 minutes, blocked with 10% normal goat serum, and
incubated with primary antibodies anti-STRO-1 (Develop-
mental Studies Hybridoma Bank, Iowa City, IA, USA),
anti-SSEA-4 (Millipore, Billerica, MA, USA), or anti-
CD146 (Abcam) for 1 hour or overnight. In negative con-
trols, primary antibodies were replaced by an appropriate
isotype-matched negative IgM or IgG. Cells were incu-
bated with AlexaFluor 488 conjugated anti-mouse IgM
(Invitrogen) or IgG (Invitrogen).
Cell nuclei were stained with 4′6-diamidino-2-phenylin-
dole (DAPI) (Invitrogen). Analysis of immunofluorescenceFigure 2 Comparison of the effect of key inflammatory regulators on
necrosis factor-alpha (TNF-α) was the only cytokine that remarkably increas
embryonic antigen 4 (SSEA-4). Although TNF-α and interleukin-1-beta (IL-1β
of them did not enhance the TNF-α effect. Results are representative of atstaining was performed under a microscope (Biozero
BZ-8000; Keyence Corp., Osaka, Japan).Colony-forming assay
Colony-forming unit-fibroblast (CFU-F) assay was per-
formed by seeding 100 cells in a 25-cm2 culture flask
and culture for 2 weeks. Cells were washed with PBS
and stained with 0.1% toluidine blue contained in 1%
PFA overnight. On the following day, flasks were washed
to remove excess dye, and only stained clusters contain-
ing more than 50 cells were counted as colonies.Migration assay
Migration assay was performed in accordance with the
Boyden chamber method, using cell culture inserts with
a light-opaque polyethylene terephthalate 8-μm micro-
porous membrane (BD Falcon HTS FluoroBlok inserts;
BD Biosciences). DPCs were dissociated with accutase,
counted, and incubated with 5 μg/mL of calcein AM
(BD Biosciences) for 15 minutes at 37°C and 5% CO2.
Cells were washed with PBS, centrifuged, and resus-
pended with serum-starved (1% FBS) medium. Cells
were counted one more time, seeded in the upper cham-
ber (cell insert), and incubated for 24 hours. Subse-
quently, cells were fixed with 4% PFA, washed with PBS,
and observed under the microscope. The total number
of migrated cells observed in the bottom of the chamberthe stem cell phenotype of dental pulp stems (DPCs). Tumor
ed the percentage of cells positive for CD146 and stage-specific
) have been reported to present a synergistic effect, the combination
least three independent experiments.
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Telomerase activity
Telomerase activity in DPCs was detected by using a
quantitative telomerase detection kit (Allied Biotech,
Inc., Ijamsville, MD, USA) in accordance with the protocol
of the manufacturer.
Statistical analysis
An unpaired Student t test or one-way analysis of variance
followed by Tukey post hoc correction test was used for
statistical analysis with GraphPad Prism (GraphPad Soft-
ware Inc., San Diego, CA, USA). P values of less than 0.05
were considered to be statistically significant.
Results
Increase in CD146+ cells during pulpal inflammatory
response in vivo
In an attempt to identify a correlation between the in-
flammatory response and changes in stem cell markers
of DPCs in vivo, we performed immunostaining for
CD146+ cells after 2 and 4 days of pulp exposure.Figure 3 A short-term treatment with tumor necrosis factor-alpha (TN
(DPCs). (A) Immunofluorescence analysis of expression of stem cell marker
upon TNF-α treatment. Treatment with TNF-α markedly increased the num
of expression of SSEA-4 and CD146. TNF-α treatment increased by twofold
decreased the percentage of SSEA-4+ and CD146+ cells, demonstrating tha
stage. (C) Effects of TNF-α pretreatment on mRNA levels of stem cell marke
expression of OCT-4 and NANOG. (D) Analysis of telomerase activity between T
telomerase activity of DPCs. *P <0.05, **P <0.01, unpaired t test. Images and gInterestingly, there was a marked increase in the num-
ber of CD146+ cells at 2 days, and this subsequently de-
creased at day 4 after pulp exposure (Figure 1). These
results indicate that an inflammatory response can in-
duce remarkable increases in CD146+ cells.
Effect of inflammatory cytokines on stem cell phenotype
of human dental pulp cells in vitro
To address whether inflammatory cytokines could regulate
the stem cell phenotype of DPCs, we proceeded to further
in vitro experiments to analyze the effect of key regulators
of inflammatory response—TNF-α, IL-1β, and IL-6—on
the stem cell phenotype of human DPCs, which were pre-
viously characterized by surface antigen expression before
assays (Additional file 1: Figure S1). As shown in Figure 2,
TNF-α remarkably increased the number of cells positive
for CD146 and SSEA-4, whereas no significant effect
could be observed by IL-1β or IL-6 stimulation. Addition-
ally, since TNF-α and IL-1β are known to have synergistic
effects, a combination of the two cytokines was also exam-
ined; however, no substantial alteration in either CD146 or
SSEA-4 markers was observed between TNF-α alone or in
combination with IL-1β (Figure 2).F-α) enhances the stem cell phenotype of dental pulp stems
s STRO-1, CD146, and stage-specific embryonic antigen 4 (SSEA-4)
ber of cells positive for the three markers. (B) Flow cytometric analysis
the number of cells positive for SSEA-4. Odontogenic differentiation
t expression of these markers is closely related to their differentiation
rs OCT-4 and NANOG. TNF-α treatment significantly increased the gene
NF-α-treated and untreated DPCs. TNF-α treatment significantly increased
raphs are representative of at least three different experiments.
Figure 4 A short-term treatment with tumor necrosis factor-
alpha (TNF-α) enhances migration and colony-forming ability of
dental pulp stems (DPCs). (A) Analysis of colony-forming ability of
DPCs. Treatment with TNF-α increased the ability of DPCs to form
colonies. The graph on the right shows the quantitative analysis of
the total number of cell clusters containing more than 50 cells. Data
are representative of three independent experiments performed
with triplicate samples. (B) Migration assay of DPCs. The images on
the left are representative of three different experiments. The graph
on the right shows the quantitative analysis of the total number of
migrated cells counted in four different pictures taken from each
chamber. TNF-α-treated DPCs presented higher migration ability
compared with untreated controls. ***P <0.001, unpaired t test.
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necrosis factor-alpha
Next, we investigated the effect of TNF-α on the stem-
ness of DPCs. To optimize the experimental protocol,
we first analyzed DPC viability and changes in stem cell
markers in response to increasing doses or increasing in-
cubation periods with TNF-α. As shown in Additional
file 2: Figure S2A, TNF-α did not affect the viability of
DPCs at any concentration. The TNF-α-induced increase
in the number of SSEA-4+ cells was also not affected by
different dosages of TNF-α (Additional file 2: Figure S2B).
Therefore, we applied TNF-α at a concentration of 10 ng/
mL in the subsequent assays.
On the other hand, a time-dependent analysis of the
TNF-α effect showed a significant decrease in cell viabil-
ity when the incubation period extended for consecutive
6 days (Additional file 2: Figure S2C), and this could ex-
plain, in part, the inhibitory effect of long-term treat-
ment of TNF-α on DPC differentiation (Additional file 2:
Figure S2D, right panels). We also incubated DPCs with
TNF-α for consecutive 4 days and observed no changes
in CD146 or OCT-4 mRNA levels (Additional file 2:
Figure S2E-F). Therefore, based on the in vivo results
showing an intense staining for CD146 at 2 days after
pulp exposure as well as on the fact that the inflamma-
tory period is normally terminated within 48 hours, we
established the experimental protocol by incubating
DPCs with TNF-α for 2 days, then passaged cells in
order to completely eliminate TNF-α from medium, and
cultured the cells for additional days before utilization in
subsequent assays.
A short-term tumor necrosis factor-alpha treatment
enhances stem cell phenotype, function, and
differentiation of dental pulp stems
Immunofluorescence studies showed that a few DPCs
were stained positively for STRO-1, CD146, and SSEA-4
(Figure 3A, left panels). Interestingly, treatment with
TNF-α markedly enhanced the percentage of cells that
stained positive for the three markers (Figure 3A, right
panels). Consistently, FCM analysis also demonstrated
an increase in the percentage of cells positive for SSEA-4
and CD146 upon TNF-α treatment (Figure 3B, left and
middle panels), with a notable decrease after odontogenic
differentiation (Figure 3B, right panels), indicating that ex-
pression of these cell surface markers is associated directly
with their differentiation stage. Consistently, TNF-α also
increased mRNA levels of OCT-4 and NANOG as well as
telomerase activity of DPCs (Figure 3C,D).
To address the possibility that the increase in stem cell
phenotype and telomerase activity could be associated
with changes in the function of DPCs, we compared
colony-forming ability, which is one major characteristic
of mesenchymal stem/progenitor cells, as well asmigration ability between TNF-α-treated and control
DPCs. As shown in Figure 4, stimulation with TNF-α
significantly enhanced the ability of DPCs to form col-
onies (Figure 4A) and to migrate (Figure 4B), as shown
by either representative images or quantitative analysis
of the assays.
On the other hand, we also investigated the multipotent
differentiation ability of DPCs, and the results showed that
TNF-α treatment enhanced odontogenic and adipogenic
differentiation of DPCs, as determined by ALP activity as
well as alizarin red staining and oil red O staining, respect-
ively (Figure 5A-C). Consistently, significant increases in
the mRNA levels of odontogenic markers ALP, DSPP,
OPN, and OCN (Figure 5B) and in the level of the adipo-
genic marker AP2 were observed in the TNF-α-treated
cells.
Figure 5 Comparative analysis of differentiation capacity between tumor necrosis factor-alpha (TNF-α)-treated and untreated dental
pulp stems (DPCs). TNF-α treatment induced a great deposition of calcified matrix as detected by alizarin red staining and alkaline phosphatase
(A) as well as the mRNA levels of DSPP, ALP, OPN, and OCN (B). Increased adipogenic differential ability was also observed in TNF-α-treated DPCs,
determined by staining with oil red O and increase in mRNA levels of AP2 (C). *P <0.05, ***P <0.001, unpaired t test. Data are representative of
three independent experiments. Scale bar = 100 μm.
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factor-alpha effect
We performed numerous experiments in attempt to
identify the mechanisms behind the TNF-α regulation of
the stem cell phenotype of DPCs. Firstly, we performed
inhibition assays by neutralization of TNFR1. To determine
the optimal functional concentration of the TNFR1AB,
we analyzed phosphorylation of nuclear factor-kappa-B
(NF-κB) upon increasing doses of the antibody. As shown
in Figure 6A, TNFR1AB promoted a dose-dependent in-
hibition of TNF-α-induced NF-κB phosphorylation, and a
satisfactory neutralization was achieved with a concentra-
tion of 10 μg/mL. We investigated changes in stem cell
markers upon blockade of TNFR1. Nevertheless, as shown
in Figure 6B, TNFR1AB could only partially suppress the
TNF-α-induced increase in the number of SSEA-4+ cells
or in NANOG mRNA levels, although OCT-4 mRNA
levels could be completely nullified (Figure 6C).
Additionally, we examined a direct inhibition of NF-κB
phosphorylation with chemical inhibitors (pyrrolidine di-
thiocarbamate and BAY 11–7082). The results, however,
showed minimal changes in the stem cell phenotype of
DPCs despite a complete inhibition of NF-κB phosphoryl-
ation (data not shown). These results demonstrate thatthe effect of TNF-α in enhancing DPC stem cell pheno-
type is in part through NF-κB signaling pathway, although
a distinct mechanism is also involved in this process.
Discussion
Inflammatory cytokines play fundamental roles during the
process of wound healing and normal tissue regeneration.
However, the mechanisms behind the cascade of biochem-
ical events related to tissue inflammation/regeneration
remain unclear. In the present work, we show that in-
flammation in the pulp is associated with increased ex-
pression of CD146, which could be related to stem/
progenitor cell migration to the injured site or a possible
enhancement of stem cell phenotype of stem/progenitor
cells in situ. These results are in agreement with previous
studies that also showed an increase in stem/progenitor
cells during wound healing in a femur fracture model [3].
In vitro studies confirmed that TNF-α, when applied for
a short period, induces significant and positive changes in
the stem cell phenotype of DPCs by increasing not only
the expression of stem cell markers but also telomerase
activity of the cells. By FCM analysis, we demonstrated
that stem cell phenotype (percentage of SSEA-4+ cells)
[16] is intimately associated with their differentiation
Figure 6 Inhibition assays with antibody against tumor necrosis factor-receptor 1 (TNFR1AB). (A) Analysis of nuclear factor-kappa-B (NF-κB)
phosphorylation upon blockade of TNFR1. Dental pulp stems (DPCs) were incubated with different concentrations (0, 4, 6, and 10 μg/mL) of
TNFR1AB for 1 hour prior to treatment with TNF-α (10 ng/mL). Phosphorylation of NF-κB (p65, p105) was examined by Western blot at 5 minutes
after stimulation. TNFR1AB inhibited TNF-α-induced phosphorylation of p105 and p65 in a dose-dependent manner, and a maximum effect was
observed with a concentration of 10 μg/mL. (B) Flow cytometric analysis of expression of stage-specific embryonic antigen 4 (SSEA-4). TNFR1AB
only partially inhibited TNF-α-induced increase in the number of SSEA-4+ cells. (C) Analysis of mRNA levels of OCT-4 and NANOG upon inhibition
of TNFR1. Although TNF-α treatment increased the gene expression of OCT-4 and NANOG, TNFR1AB nullified the TNF-α-induced increase OCT-4
mRNA levels only. **P <0.01, one-way analysis of variance (ANOVA), Tukey test. Data are representative of at least three different experiments.
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TNF-α-enhanced stem cell phenotype resulted in in-
creased differentiation ability of the cells.
The role of TNF-α on cell migration as a chemo-
attractant factor has also been largely reported during
tissue healing process, including migration of smooth
muscle cells or mesenchymal stem cells [17-20]. Inter-
estingly, however, our experimental model shows that
TNF-α-enhanced cell migration is possibly associated
with changes in the intracellular machinery that is ex-
tended even after subsequent cell passages, and this is a
novel finding compared with the well-known chemo-
attractant effect of TNF-α. Cell migration is known as a
dynamic process regulated by actin filament remodel-
ing, but only a few studies have reported on the effect of
TNF-α on regulation of actin filament organization
[21], and the mechanisms underlying this process are
still largely unknown.
DPCs consist of a heterogeneous cell population;
therefore, it is not clear from the present results whether
the increase in the percentage of cells positive for stem cell
surface markers is associated with an increase in the num-
ber of existing stem/progenitor cells or an increase in stemcell phenotype of differentiated cells. A recent article has
demonstrated that NF-κB activity is required for cell re-
programming and induction of pluripotency by retroviral
overexpression of reprogramming factors (Oct4, Sox2,
Klf4, c-Myc) [22]. In the present investigation, since we
analyzed the effect of TNF-α alone, we could not observe
dramatic changes in stem cell phenotype as compared
with reprogramming of induced pluripotent stem cells.
Nonetheless, we demonstrate the importance of TNF-α
and NF-κB signaling in regulating the stem cell phenotype
of adult tissue-derived stem/progenitor cells.
Our findings also demonstrate that NF-κB is not the
only pathway involved in the TNF-α-enhanced stem cell
phenotype of DPCs, since neutralization of TNFR1 by
TNFR1AB or chemical blockade of NF-κB did not nullify
the TNF-α-induced increase in stem cell markers, des-
pite a complete inhibition of NF-κB phosphorylation.
Additionally, we have investigated the involvement of
other candidate signaling pathways, such as p38/MAP
kinase; however, blockade of p38/MAPK with a specific
inhibitor, SB-202190, could not rescue TNF-α-induced
increase in the percentage of SSEA-4+ cells (data not
shown). These results demonstrate that TNF-α regulation
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intra-cellular pathways, and this demands additional com-
prehensive investigation.
Conclusions
The present data show that short-term treatment with
TNF-α significantly increases the stem cell phenotype of
DPCs and their function and multipotent differentiation
ability. These data are expected to greatly contribute to
the understanding of the complex process involved in
tissue healing/regeneration and to the research field of
stem cell biology and regenerative medicine.
Additional files
Additional file 1: Figure S1. Analysis of cell surface markers by flow
cytometry. Isolated dental pulp cells (DPCs) were positive for mesenchymal
stem cell markers, including stage-specific embryonic antigen 4 (SSEA-4),
CD146, CD29, CD44, and CD90, but were negative for hematopoietic stem
cell markers CD34 and CD45.
Additional file 2: Figure S2. Optimization of the experimental
protocol. Analysis of cell viability of dental pulp cells (DPCs) was measured
by MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium) assay. (A) No significant difference in cell
viability was observed when DPCs were stimulated with increasing doses of
tumor necrosis factor-alpha (TNF-α) for 3 days. (B) A time-dependent
analysis of cell viability after DPCs were incubated with TNF-α (10 ng/mL) for
2, 4, or 6 days. A significant decrease in cell viability was observed only when
the incubation period extended for 6 consecutive days. ***P <0.001 (one
way analysis of variance/Tukey) compared with day-0 group. (C) Left panels
show the differentiation capacity of DPCs toward odontogenic and
adipogenic lineage. Right panels show that a long-term TNF-α treatment
(odontogenic differentiation = 21 days, adipogenic differentiation = 30 days)
suppresses DPC differentiation. (D) TNF-α-induced increase in stage-
specific embryonic antigen 4 (SSEA-4) levels was similar with different
concentrations of the cytokine. (E,F) TNF-α stimulation for 4 days did
not increase either the number of SSEA-4+ cells or mRNA levels of
octamer-binding transcription factor 4 (OCT-4). All experiments were
performed with at least triplicate samples.
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